Bevurogant

CAS No. 1817773-66-2

Bevurogant( —— )

Catalog No. M28214 CAS No. 1817773-66-2

Bevurogant is an antagonist of RORγt receptor and can be used in studies about the treatment of chronic inflammatory diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 447 Get Quote
10MG 651 Get Quote
25MG 1017 Get Quote
50MG 1368 Get Quote
100MG 1782 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Bevurogant
  • Note
    Research use only, not for human use.
  • Brief Description
    Bevurogant is an antagonist of RORγt receptor and can be used in studies about the treatment of chronic inflammatory diseases.
  • Description
    Bevurogant is an antagonist of RORγt receptor and can be used in studies about the treatment of chronic inflammatory diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Nuclear Receptor/Transcription Factor
  • Target
    ROR
  • Recptor
    p53
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1817773-66-2
  • Formula Weight
    532.62
  • Molecular Formula
    C26H28N8O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (469.38 mM)
  • SMILES
    [C@@H](C)(N1C=2C(N=C(NCC3=CC=C(S(C)(=O)=O)C=N3)C1=O)=CN=C(N2)C=4C(=NC=NC4C)C5CC5)C6CC6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Messerli M, et al. Emphysema quantification and lung volumetry in chest X-ray equivalent ultralow dose CT - Intra-individual comparison with standard dose CT. Eur J Radiol. 2017 Jun;91:1-9.
molnova catalog
related products
  • GSK805

    GSK805 is a potent orally bioavailable retinoid-related orphan receptor gamma t (RORγt) inverse agonist that interacts with the receptor's putative ligand binding domain without exerting significant effects on DNA binding.

  • S18-000003

    S18-000003 is an effective orally bioavailable retinoic acid receptor-related orphan receptor-gamma-t inhibitor (IC50: 29 nM).

  • SR3335

    SR 3335 is a selective inverse agonist of RORα competitively inhibiting the binding of 25-hydroxycholesterol to the ligand binding domain (Ki: 220 nM).